Evidence map›Paper›PMID 28894007›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

RABIF/MSS4 is a Rab-stabilizing holdase chaperone required for GLUT4 exocytosis.

Daniel R Gulbranson, Eric M Davis, Brittany A Demmitt, Yan Ouyang, Yihong Ye, Haijia Yu, Jingshi Shen

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Phosphorylation of Arl4A/D promotes their binding by the HYPK chaperone for their stable recruitment to the plasma membrane.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Daniel R GulbransonDepartment of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309.
Eric M DavisDepartment of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309.
Brittany A DemmittDepartment of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309.
Yan OuyangDepartment of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309.
Yihong YeLaboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.
Haijia YuDepartment of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309; haijiayu@gmail.com jingshi.shen@colorado.edu.
Jingshi ShenDepartment of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309; haijiayu@gmail.com jingshi.shen@colorado.edu.
University of Colorado Boulder · USNanjing Normal University · CNNational Institutes of Health · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Regulatory Mechanisms of GLUT4 ExocytosisR01DK095367 · NIDDK · UNIVERSITY OF COLORADO · PI SHEN, JINGSHI · 2013 to 2017
$1.7M
Protein-Membrane Interactions in Regulated ExocytosisR01GM102217 · NIGMS · UNIVERSITY OF COLORADO · PI SHEN, JINGSHI · 2013 to 2017
$1.5M
Regulatory Mechanisms of GLUT4 ExocytosisR56DK095367 · NIDDK · UNIVERSITY OF COLORADO · PI SHEN, JINGSHI · 2012 to 2018
$598k
NCI NIH HHS P30 CA046934NIDDK NIH HHS R01 DK095367NIDDK NIH HHS R56 DK095367NIGMS NIH HHS R01 GM102217
6 · The paper itself

Abstract

Rab GTPases are switched from their GDP-bound inactive conformation to a GTP-bound active state by guanine nucleotide exchange factors (GEFs). The first putative GEFs isolated for Rabs are RABIF (Rab-interacting factor)/MSS4 (mammalian suppressor of Sec4) and its yeast homolog DSS4 (dominant suppressor of Sec4). However, the biological function and molecular mechanism of these molecules remained unclear. In a genome-wide CRISPR genetic screen, we isolated RABIF as a positive regulator of exocytosis. Knockout of

Indexed as

AdipocytesAnimalsCell Line, TumorCRISPR-Cas SystemsExocytosisGlucose Transporter Type 4Guanine Nucleotide Exchange FactorsHEK293 CellsHeLa CellsHumansMiceMolecular ChaperonesProtein Transportrab GTP-Binding ProteinsTransport VesiclesGlucose Transporter Type 4Guanine Nucleotide Exchange FactorsMolecular ChaperonesRab10 protein, humanRAB13 protein, humanRAB8A protein, humanrab GTP-Binding ProteinsRABIF protein, humanSLC2A4 protein, humanCRISPR screenexocytosisGLUT4Rab GTPasevesicle transport

Identifiers

PMID28894007
PMCPMC5625932
OpenAlexW2755239475

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.